A comprehensive view of Laboratory Corp. of America Holdings (LabCorp). This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Geneoscopy's new noninvasive colorectal cancer screening test, Colosense, receives FDA approval for people aged 45 or older; the test to be offered by Labcorp
Published: May 08, 2024 by MedTech Dive
Labcorp to webcast Its annual meeting of shareholders on May 14 at 9:00 a.m. ET on the Labcorp Investor Relations website
Published: May 08, 2024 by Laboratory Corp. of America Holdings (LabCorp)
Invitae Receives Court Approval for Sale to Labcorp
Published: May 07, 2024 by Laboratory Corp. of America Holdings (LabCorp)
FDA approves Labcorp's nAbCyte, a diagnostic test to determine patient eligibility for Pfizer's US$3.5 million-per-dose gene therapy for hemophilia B; the test identifies specific antibodies that could interfere with the therapy's virus delivery vector
Published: April 29, 2024 by FierceBiotech
Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B
Published: April 29, 2024 by Laboratory Corp. of America Holdings (LabCorp)

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count